Lay opinion vs evidence: DNA Test Senioren

Lay opinion often suggests that a DNA test can tell seniors exactly how to age well—predicting longevity, dementia risk, or bone health. The evidence tells a different story. While GWAS have identified variants like FOXO3 rs2764264 associated with longevity, the effect is small and the variant is common (62.7% in Europeans). A single genetic marker cannot determine lifespan. Other genes, such as VDR, show only mechanistic links and are overshadowed by vitamin D status and lifestyle. MyBody-X may test some of these markers, but their predictive value for individuals is very limited. Lifestyle factors—diet, exercise, social engagement—dominate aging outcomes. Furthermore, DTC tests risk overhyping small effects, causing unnecessary anxiety or false reassurance. For seniors, the evidence does not support using DNA tests alone for health planning. The overall evidence is mixed: some markers have GWAS support, but clinical utility is low. Consumers should be cautious and prioritize modifiable factors over genetic predictions.